Importantly, a landmark study by Li et al. [18] provided compelling in vivo evidence that fibroblast-specific NLRP3 inflammasome activation directly promotes atrial cardiomyopathy, arrhythmogenesis, and heart failure with preserved ejection fraction (HFpEF). The gene discussed is NLRP3; the disease is heart failure.